CA1341246C - Therapie genique de cellules somatiques - Google Patents

Therapie genique de cellules somatiques

Info

Publication number: CA1341246C
Authority: CA; Canada
Prior art keywords: fibroblasts; matrix; factor; dermis; connective tissue
Prior art date: 1988-04-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 595744

Other languages

English (en)

Inventor

Inder Mohan Verma

Daniel Claude St. Louis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Salk Institute for Biological Studies

Original Assignee

Salk Institute for Biological Studies

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-28

Filing date

1989-04-05

Publication date

2001-06-05

1989-04-05 Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies

2001-06-05 Application granted granted Critical

2001-06-05 Publication of CA1341246C publication Critical patent/CA1341246C/fr

2018-06-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000001415 gene therapy Methods 0.000 title claims abstract description 26
210000001082 somatic cell Anatomy 0.000 title abstract description 10
108090000623 proteins and genes Proteins 0.000 claims abstract description 143
210000002950 fibroblast Anatomy 0.000 claims abstract description 117
102000004169 proteins and genes Human genes 0.000 claims abstract description 57
210000002808 connective tissue Anatomy 0.000 claims abstract description 35
210000004207 dermis Anatomy 0.000 claims abstract description 31
108010076282 Factor IX Proteins 0.000 claims description 54
102100022641 Coagulation factor IX Human genes 0.000 claims description 53
229960004222 factor ix Drugs 0.000 claims description 53
239000011159 matrix material Substances 0.000 claims description 30
238000002513 implantation Methods 0.000 claims description 24
230000001177 retroviral effect Effects 0.000 claims description 24
239000013598 vector Substances 0.000 claims description 19
102000008186 Collagen Human genes 0.000 claims description 18
108010035532 Collagen Proteins 0.000 claims description 18
229920001436 collagen Polymers 0.000 claims description 18
239000003114 blood coagulation factor Substances 0.000 claims description 16
239000000126 substance Substances 0.000 claims description 15
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 14
229940088597 hormone Drugs 0.000 claims description 12
239000005556 hormone Substances 0.000 claims description 12
230000002491 angiogenic effect Effects 0.000 claims description 11
229940079593 drug Drugs 0.000 claims description 11
239000003814 drug Substances 0.000 claims description 11
108090000790 Enzymes Proteins 0.000 claims description 9
230000014509 gene expression Effects 0.000 claims description 9
102000004190 Enzymes Human genes 0.000 claims description 8
108090001061 Insulin Proteins 0.000 claims description 8
102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 7
108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 7
108010000521 Human Growth Hormone Proteins 0.000 claims description 7
102000004877 Insulin Human genes 0.000 claims description 7
229940126864 fibroblast growth factor Drugs 0.000 claims description 7
239000003112 inhibitor Substances 0.000 claims description 7
229940125396 insulin Drugs 0.000 claims description 7
102000002265 Human Growth Hormone Human genes 0.000 claims description 6
239000000854 Human Growth Hormone Substances 0.000 claims description 6
102000002746 Inhibins Human genes 0.000 claims description 6
108010004250 Inhibins Proteins 0.000 claims description 6
239000000893 inhibin Substances 0.000 claims description 6
239000002753 trypsin inhibitor Substances 0.000 claims description 6
108010054218 Factor VIII Proteins 0.000 claims description 5
102000001690 Factor VIII Human genes 0.000 claims description 5
229960000301 factor viii Drugs 0.000 claims description 5
102000003982 Parathyroid hormone Human genes 0.000 claims description 4
108090000445 Parathyroid hormone Proteins 0.000 claims description 4
230000002611 ovarian Effects 0.000 claims description 4
239000000199 parathyroid hormone Substances 0.000 claims description 4
229960001319 parathyroid hormone Drugs 0.000 claims description 4
108700012941 GNRH1 Proteins 0.000 claims 6
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 claims 6
210000004027 cell Anatomy 0.000 abstract description 136
238000000034 method Methods 0.000 abstract description 23
241001465754 Metazoa Species 0.000 abstract description 21
210000003491 skin Anatomy 0.000 abstract description 14
238000000338 in vitro Methods 0.000 abstract description 10
102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 8
108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 8
210000002744 extracellular matrix Anatomy 0.000 abstract description 8
201000010099 disease Diseases 0.000 abstract description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
230000007547 defect Effects 0.000 abstract description 3
229960000027 human factor ix Drugs 0.000 description 44
241001430294 unidentified retrovirus Species 0.000 description 43
241000699670 Mus sp. Species 0.000 description 29
241000699666 Mus <mouse, genus> Species 0.000 description 21
235000018102 proteins Nutrition 0.000 description 21
210000002966 serum Anatomy 0.000 description 18
210000001626 skin fibroblast Anatomy 0.000 description 18
239000007943 implant Substances 0.000 description 17
108020004414 DNA Proteins 0.000 description 15
241000700605 Viruses Species 0.000 description 13
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
239000002299 complementary DNA Substances 0.000 description 9
208000015181 infectious disease Diseases 0.000 description 9
230000000890 antigenic effect Effects 0.000 description 8
239000002609 medium Substances 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
108010039209 Blood Coagulation Factors Proteins 0.000 description 7
102000015081 Blood Coagulation Factors Human genes 0.000 description 7
239000000501 collagen implant Substances 0.000 description 7
239000000523 sample Substances 0.000 description 7
108020000999 Viral RNA Proteins 0.000 description 6
239000001963 growth medium Substances 0.000 description 6
239000003550 marker Substances 0.000 description 6
230000028327 secretion Effects 0.000 description 6
101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 5
239000000020 Nitrocellulose Substances 0.000 description 5
101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 5
238000003556 assay Methods 0.000 description 5
238000012258 culturing Methods 0.000 description 5
230000002950 deficient Effects 0.000 description 5
210000002615 epidermis Anatomy 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
239000000463 material Substances 0.000 description 5
229920001220 nitrocellulos Polymers 0.000 description 5
230000003612 virological effect Effects 0.000 description 5
238000011740 C57BL/6 mouse Methods 0.000 description 4
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 4
102100024028 Progonadoliberin-1 Human genes 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000007423 decrease Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 4
210000001161 mammalian embryo Anatomy 0.000 description 4
230000017074 necrotic cell death Effects 0.000 description 4
230000001566 pro-viral effect Effects 0.000 description 4
210000000130 stem cell Anatomy 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
230000002463 transducing effect Effects 0.000 description 4
238000010361 transduction Methods 0.000 description 4
230000026683 transduction Effects 0.000 description 4
238000012546 transfer Methods 0.000 description 4
210000002845 virion Anatomy 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
241000282465 Canis Species 0.000 description 3
102000018997 Growth Hormone Human genes 0.000 description 3
108010051696 Growth Hormone Proteins 0.000 description 3
101000976075 Homo sapiens Insulin Proteins 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
229930003448 Vitamin K Natural products 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000013459 approach Methods 0.000 description 3
108700004025 env Genes Proteins 0.000 description 3
101150030339 env gene Proteins 0.000 description 3
230000035558 fertility Effects 0.000 description 3
239000012091 fetal bovine serum Substances 0.000 description 3
239000012634 fragment Substances 0.000 description 3
239000000122 growth hormone Substances 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
239000003018 immunosuppressive agent Substances 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
210000002510 keratinocyte Anatomy 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
230000008569 process Effects 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
231100000588 tumorigenic Toxicity 0.000 description 3
230000000381 tumorigenic effect Effects 0.000 description 3
235000019168 vitamin K Nutrition 0.000 description 3
239000011712 vitamin K Substances 0.000 description 3
150000003721 vitamin K derivatives Chemical class 0.000 description 3
229940046010 vitamin k Drugs 0.000 description 3
238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
208000031220 Hemophilia Diseases 0.000 description 2
208000009292 Hemophilia A Diseases 0.000 description 2
229920000209 Hexadimethrine bromide Polymers 0.000 description 2
241000282412 Homo Species 0.000 description 2
208000026350 Inborn Genetic disease Diseases 0.000 description 2
108010025815 Kanamycin Kinase Proteins 0.000 description 2
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
241000714177 Murine leukemia virus Species 0.000 description 2
241001045988 Neogene Species 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
238000000636 Northern blotting Methods 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
206010038997 Retroviral infections Diseases 0.000 description 2
108091058545 Secretory proteins Proteins 0.000 description 2
102000040739 Secretory proteins Human genes 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
210000002469 basement membrane Anatomy 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000035602 clotting Effects 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000010432 diamond Substances 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
238000012377 drug delivery Methods 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
229940125721 immunosuppressive agent Drugs 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
101150091879 neo gene Proteins 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
239000002245 particle Substances 0.000 description 2
210000003200 peritoneal cavity Anatomy 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
239000003488 releasing hormone Substances 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000010839 reverse transcription Methods 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
210000004927 skin cell Anatomy 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
210000005253 yeast cell Anatomy 0.000 description 2
PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
-1 Cd++ ions Chemical class 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
206010016228 Fasciitis Diseases 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
241000726306 Irus Species 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
108010000499 Thromboplastin Proteins 0.000 description 1
102000002262 Thromboplastin Human genes 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000011149 active material Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
239000002870 angiogenesis inducing agent Substances 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
244000309466 calf Species 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000001612 chondrocyte Anatomy 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000000512 collagen gel Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
210000001608 connective tissue cell Anatomy 0.000 description 1
238000012364 cultivation method Methods 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
235000013305 food Nutrition 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000008348 humoral response Effects 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
229940126701 oral medication Drugs 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000008520 organization Effects 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
210000001778 pluripotent stem cell Anatomy 0.000 description 1
108700004029 pol Genes Proteins 0.000 description 1
101150088264 pol gene Proteins 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000006152 selective media Substances 0.000 description 1
238000007390 skin biopsy Methods 0.000 description 1
239000000243 solution Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000012360 testing method Methods 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000032258 transport Effects 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
230000006459 vascular development Effects 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA 595744 1988-04-28 1989-04-05 Therapie genique de cellules somatiques Expired - Fee Related CA1341246C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18721488A	1988-04-28	1988-04-28
US187,214		1988-04-28

Publications (1)

Publication Number	Publication Date
CA1341246C true CA1341246C (fr)	2001-06-05

Family

ID=22688062

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 595744 Expired - Fee Related CA1341246C (fr)	1988-04-28	1989-04-05	Therapie genique de cellules somatiques

Country Status (1)

Country	Link
CA (1)	CA1341246C (fr)

1989
- 1989-04-05 CA CA 595744 patent/CA1341246C/fr not_active Expired - Fee Related

Legal Events

Date	Code	Title	Description
2004-06-07	MKLA	Lapsed

Publication	Publication Date	Title
WO1992015676A1 (fr)	1992-09-17	Therapie genique par les cellules somatiques
St Louis et al.	1988	An alternative approach to somatic cell gene therapy.
AU659824B2 (en)	1995-06-01	Retroviral vectors useful for gene therapy
US5698436A (en)	1997-12-16	Introduction and expression of foreign genetic material in epithelial cells
US4980286A (en)	1990-12-25	In vivo introduction and expression of foreign genetic material in epithelial cells
US5460959A (en)	1995-10-24	Transduced fibroblasts
US5674722A (en)	1997-10-07	Genetic modification of endothelial cells
Naffakh et al.	1995	Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.
US6140111A (en)	2000-10-31	Retroviral gene therapy vectors and therapeutic methods based thereon
JPH09509571A (ja)	1997-09-30	クローン原性線維芽細胞を調製する方法、線維芽細胞を遺伝子トランスフェクションする方法及びかくして得られた遺伝子トランスフェクション線維芽細胞
JPH11509171A (ja)	1999-08-17	単離されたストロマ細胞と当該細胞を使用する方法
US6544771B1 (en)	2003-04-08	Retroviral gene therapy vectors and therapeutic methods based thereon
US6001350A (en)	1999-12-14	Genetic modification of endothelial cells
Petersen et al.	1995	Sustained production of human transferrin by transduced fibroblasts implanted into athymic mice: a model for somatic gene therapy
WO1996006933A1 (fr)	1996-03-07	Therapie genique destinee a la transplantation et a des etats inflammatoires ou thrombotiques
CA1341246C (fr)	2001-06-05	Therapie genique de cellules somatiques
JP2009201518A (ja)	2009-09-10	Ｌｃａｔ欠損症の遺伝子治療用細胞並びにこれを産生するのに用いられる複製欠損性レトロウイルスベクター及びプラスミド
US6645942B1 (en)	2003-11-11	Somatic cell gene therapy
AU709477C (en)	2000-09-07	Retroviral gene therapy vectors and therapeutic methods based thereon